BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 21068433)

  • 1. Genetics of fetal hemoglobin in Tanzanian and British patients with sickle cell anemia.
    Makani J; Menzel S; Nkya S; Cox SE; Drasar E; Soka D; Komba AN; Mgaya J; Rooks H; Vasavda N; Fegan G; Newton CR; Farrall M; Thein SL
    Blood; 2011 Jan; 117(4):1390-2. PubMed ID: 21068433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA polymorphisms at BCL11A, HBS1L-MYB and Xmn1-HBG2 site loci associated with fetal hemoglobin levels in sickle cell anemia patients from Northern Brazil.
    Cardoso GL; Diniz IG; Silva AN; Cunha DA; Silva Junior JS; Uchôa CT; Santos SE; Trindade SM; Cardoso Mdo S; Guerreiro JF
    Blood Cells Mol Dis; 2014 Dec; 53(4):176-9. PubMed ID: 25084696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional polymorphisms of BCL11A and HBS1L-MYB genes affect both fetal hemoglobin level and clinical outcomes in a cohort of children with sickle cell anemia.
    Sales RR; Belisário AR; Faria G; Mendes F; Luizon MR; Viana MB
    Ann Hematol; 2020 Jul; 99(7):1453-1463. PubMed ID: 32447424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal hemoglobin in sickle cell anemia: molecular characterization of the unusually high fetal hemoglobin phenotype in African Americans.
    Akinsheye I; Solovieff N; Ngo D; Malek A; Sebastiani P; Steinberg MH; Chui DH
    Am J Hematol; 2012 Feb; 87(2):217-9. PubMed ID: 22139998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of variants at BCL11A and HBS1L-MYB with hemoglobin F and hospitalization rates among sickle cell patients in Cameroon.
    Wonkam A; Ngo Bitoungui VJ; Vorster AA; Ramesar R; Cooper RS; Tayo B; Lettre G; Ngogang J
    PLoS One; 2014; 9(3):e92506. PubMed ID: 24667352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome wide association study of fetal hemoglobin in sickle cell anemia in Tanzania.
    Mtatiro SN; Singh T; Rooks H; Mgaya J; Mariki H; Soka D; Mmbando B; Msaki E; Kolder I; Thein SL; Menzel S; Cox SE; Makani J; Barrett JC
    PLoS One; 2014; 9(11):e111464. PubMed ID: 25372704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants associated with fetal hemoglobin levels show the diverse ethnic origin in Colombian patients with sickle cell anemia.
    Fong C; Menzel S; Lizarralde MA; Barreto G
    Biomedica; 2015; 35(3):437-43. PubMed ID: 26849705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variants at HbF-modifier loci moderate anemia and leukocytosis in sickle cell disease in Tanzania.
    Mtatiro SN; Makani J; Mmbando B; Thein SL; Menzel S; Cox SE
    Am J Hematol; 2015 Jan; 90(1):E1-4. PubMed ID: 25263325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal hemoglobin regulating genetic variants identified in homozygous (HbSS) and heterozygous (HbSA) subjects from South Mexico.
    Rizo-de la Torre LC; Borrayo-López FJ; Perea-Díaz FJ; Aquino E; Venegas M; Hernández-Carbajal C; Espinoza-Mata LL; Ibarra-Cortés B
    J Trop Pediatr; 2022 Aug; 68(5):. PubMed ID: 36130307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease.
    Lettre G; Sankaran VG; Bezerra MA; Araújo AS; Uda M; Sanna S; Cao A; Schlessinger D; Costa FF; Hirschhorn JN; Orkin SH
    Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11869-74. PubMed ID: 18667698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetics of hemoglobin A2 regulation in sickle cell anemia.
    Griffin PJ; Sebastiani P; Edward H; Baldwin CT; Gladwin MT; Gordeuk VR; Chui DH; Steinberg MH
    Am J Hematol; 2014 Nov; 89(11):1019-23. PubMed ID: 25042611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of fetal hemoglobin in sickle cell anemia using an ensemble of genetic risk prediction models.
    Milton JN; Gordeuk VR; Taylor JG; Gladwin MT; Steinberg MH; Sebastiani P
    Circ Cardiovasc Genet; 2014 Apr; 7(2):110-5. PubMed ID: 24585758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between BCL11A, HSB1L-MYB, and XmnI γG-158 (C/T) gene polymorphism and hemoglobin F level in Egyptian sickle cell disease patients.
    El-Ghamrawy M; Yassa ME; Tousson AMS; El-Hady MA; Mikhaeil E; Mohamed NB; Khorshied MM
    Ann Hematol; 2020 Oct; 99(10):2279-2288. PubMed ID: 32772141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of fetal hemoglobin in tribal Indian patients with sickle cell anemia.
    Bhanushali AA; Patra PK; Pradhan S; Khanka SS; Singh S; Das BR
    Transl Res; 2015 Jun; 165(6):696-703. PubMed ID: 25651163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans.
    Bae HT; Baldwin CT; Sebastiani P; Telen MJ; Ashley-Koch A; Garrett M; Hooper WC; Bean CJ; Debaun MR; Arking DE; Bhatnagar P; Casella JF; Keefer JR; Barron-Casella E; Gordeuk V; Kato GJ; Minniti C; Taylor J; Campbell A; Luchtman-Jones L; Hoppe C; Gladwin MT; Zhang Y; Steinberg MH
    Blood; 2012 Aug; 120(9):1961-2. PubMed ID: 22936743
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic association of fetal-hemoglobin levels in individuals with sickle cell disease in Tanzania maps to conserved regulatory elements within the MYB core enhancer.
    Mtatiro SN; Mgaya J; Singh T; Mariki H; Rooks H; Soka D; Mmbando B; Thein SL; Barrett JC; Makani J; Cox SE; Menzel S
    BMC Med Genet; 2015 Feb; 16():4. PubMed ID: 25928412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A candidate transacting modulator of fetal hemoglobin gene expression in the Arab-Indian haplotype of sickle cell anemia.
    Vathipadiekal V; Farrell JJ; Wang S; Edward HL; Shappell H; Al-Rubaish AM; Al-Muhanna F; Naserullah Z; Alsuliman A; Qutub HO; Simkin I; Farrer LA; Jiang Z; Luo HY; Huang S; Mostoslavsky G; Murphy GJ; Patra PK; Chui DH; Alsultan A; Al-Ali AK; Sebastiani P; Steinberg MH
    Am J Hematol; 2016 Nov; 91(11):1118-1122. PubMed ID: 27501013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genetic dissection of fetal haemoglobin persistence in sickle cell disease in Nigeria.
    Ojewunmi OO; Adeyemo TA; Oyetunji AI; Inyang B; Akinrindoye A; Mkumbe BS; Gardner K; Rooks H; Brewin J; Patel H; Lee SH; Chung R; Rashkin S; Kang G; Chianumba R; Sangeda R; Mwita L; Isa H; Agumadu UN; Ekong R; Faruk JA; Jamoh BY; Adebiyi NM; Umar IA; Hassan A; Grace C; Goel A; Inusa BPD; Falchi M; Nkya S; Makani J; Ahmad HR; Nnodu O; Strouboulis J; Menzel S
    Hum Mol Genet; 2024 May; 33(10):919-929. PubMed ID: 38339995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation.
    Galarneau G; Palmer CD; Sankaran VG; Orkin SH; Hirschhorn JN; Lettre G
    Nat Genet; 2010 Dec; 42(12):1049-51. PubMed ID: 21057501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying genetic variants and pathways associated with extreme levels of fetal hemoglobin in sickle cell disease in Tanzania.
    Nkya S; Mwita L; Mgaya J; Kumburu H; van Zwetselaar M; Menzel S; Mazandu GK; Sangeda R; Chimusa E; Makani J
    BMC Med Genet; 2020 Jun; 21(1):125. PubMed ID: 32503527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.